DrugPatentWatch Database Preview
Litigation Details for Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd. (N.D. Cal. 2013)
» See Plans and Pricing
Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd. (N.D. Cal. 2013)
| Docket | Start Trial | Date Filed | 2013-04-26 |
| Court | District Court, N.D. California | Date Terminated | 2014-09-05 |
| Cause | 35:145 Patent Infringement | Assigned To | Lucy Haeran Koh |
| Jury Demand | None | Referred To | Magistrate Judge Paul Singh Gr |
| Patents | 6,228,398; 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755; 8,105,626; 8,173,158; 8,461,187 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd. (N.D. Cal. 2013)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2013-04-26 | 1 | Paragraph lV Certifications from Handa for U.S. Patent Nos. 6,462,058; 6,664,276; 6,939,971; 7,285,668; and 7,…non-infringement of U.J. Patent Nos. 8,105,626 (“the ’626 Patent”) and 8,173,158 (“the ’158 Patent”) pursuant to …the ’158 Patent and/or the ’626 Patent, or that one or more of the Defendants will file a patent infringement…TPC is the named assignee of the ’626 Patent, 17. The ’158 Patent, entitled “Methods of Treating Gastrointestinal…Administration (“FDA”) to list the ’158 Patent and the ’626 Patent in FDA’s Approved Drug Products with | External link to document | |
| 2013-07-09 | 29 | and U.S. Patent No. 7,790,755 10 (the “’755 Patent), which…captioned matter concerns infringement of United States Patent No. 8,173,158 … (“the ’158 Patent”). On June 25, 2013, Takeda Pharmaceutical Company…each of which concerns infringement of the ’158 patent (“’158 Actions”): …which Impax alleges is similar to the ’158 Patent. See id. In those cases, (the For the Northern District | External link to document | |
| 2013-10-28 | 56 | Mylan infringed on five other patents associated with Dexilant: 6,462,058; 6,664,276; 6,939,971; … 17 patents 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755… 8 concerns the patents at issue in the ‘755 Actions and not the patents at issue in the ‘158 Actions…America, Inc. (collectively, “Takeda”) related to patents 22 …alleges that Mylan infringed on two of the Takada patents associated with Dexilant: | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
